LENBULT
LIVE

Serial Number

99382825

Owner

Glaxo Group Limited

Attorney

Elizabeth K. Rucki

Filing Date

Sep 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LENBULT Trademark

Serial Number: 99382825

LENBULT is a trademark filed by Glaxo Group Limited on September 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Glaxo Group Limited (128 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

September 9, 2025

Registration Date

Not Registered

Published for Opposition

April 21, 2026

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 9, 2025 MAFR
NEW APPLICATION ENTERED
Sep 9, 2025 NWAP